Philippines Pharmaceuticals and Healthcare Report Q4 2009

Publication Date	September 2009
Publisher	Business Monitor
Product Type	Report
Pages	101
ISBN Number	1748-376X
Product Code	BMI04008

Buy this product or for assistance call +44 20 7060 7474

PDF £250.00$416 | €280

FAX Order above formats by FAX

Summary

The Q409 update of BMI's Philippines Pharmaceuticals & Healthcare report contains for the first time a 10-year forecast for medicine expenditure. The US$2.61bn market is forecast to experience slight growth of 1.8% in 2009. This is mainly due to local currency depreciation, but also a deteriorating macroeconomic environment. Robust growth will return in 2010 and sales will reach US$4.11bn by 2013.

Through to 2018, we are forecasting a compound annual growth rate (CAGR) of 10.08%, which is one of the steepest trajectories in our 71-country coverage universe.

Despite this, the Philippines is at risk of losing its allure to multinational drugmakers. To lower prices of pharmaceuticals ??

Content

Executive Summary
SWOT Analysis
Philippines Pharmaceutical And Healthcare Industry SWOT
Philippines Political SWOT
Philippines Economic SWOT
Philippines Business Environment SWOT
Pharmaceutical Business Environment Ranking
Limits of Potential Returns
Risks to Realisation of Returns
The Philippines ??

Delivery Details

PDF:Immediate delivery

Ask a question about this product

Need help finding the right product?

Product features / use

Level	General Industry Strategies
Data	Detailed Market Forecasts
Profiles	Profiles of Key Companies
Features	Contains SWOT Analysis
Extra Info	Consumer Trends Highlighted